December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Why GE HealthCare (GEHC) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence World Trade
Tickers GEHC RY TSX:RY
Exposures Artificial Intelligence Product Safety Tariff
News headline image
Lucid vs. Rivian: Which Is Winning the Only Race That Matters? ↗
Via The Motley Fool
Topics Electric Vehicles Product Recall Supply Chain
Tickers LCID RIVN TSLA
Exposures Electric Vehicles Legal Product Safety
News headline image
FNM News Break: Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
Via FinancialNewsMedia
Tickers HELP
Exposures Product Safety
News headline image
FDA Raises No Concerns Over Auxora Safety Data, CalciMedica Advances Trial ↗
Via Benzinga
Exposures Product Safety
News headline image
White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The President' ↗
Via Benzinga
Topics Government
Tickers LLY
Exposures Political Product Safety
News headline image
Wall Street Expects This Growth Stock That's Already Climbed 70% to Almost Double -- And Here's Why. ↗
Via The Motley Fool
Tickers NTLA
Exposures Product Safety
News headline image
What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers MLYS
Exposures Legal Product Safety Regulatory
News headline image
Philip Morris (PM) Stock Is Up, What You Need To Know
Via StockStory
Topics Artificial Intelligence Stocks
Tickers NVDA PM
Exposures Artificial Intelligence Product Safety US Equities
Ford SUV Recall Highlights Potential Fuel Injector Defect and Vehicle Safety Concerns
Via AB Newswire
Topics Product Recall
Tickers F
Exposures Legal Product Safety
News headline image
Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection ↗
Via Benzinga
Exposures Product Safety
News headline image
BIS Certification in India: Meaning, Process, and Benefits ↗
Via Talk Markets
Topics Economy Product Recall
Exposures Economy Legal Product Safety
News headline image
TelehealthReviewed.com Announces Editorial Series on Provider-Guided Weight Management Platforms
Via AB Newswire
Exposures Product Safety
News headline image
Praxis' Seizure Drug Move Towards Faster Development After Positive Trial Results ↗
Via Benzinga
Exposures Product Safety
News headline image
FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned ↗
Via Benzinga
Exposures Product Safety
News headline image
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Tickers NVCR OMER
Exposures Product Safety
News headline image
STT Security Services Examines the Role of Food Production Security in Protecting Product Integrity and Operational Continuity
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
News headline image
Regenxbio Gains Fresh Chance As FDA Reconsiders Gene Therapy ↗
Via Benzinga
Exposures Product Safety
News headline image
WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy
Via Newsfile
Tickers LLY NTHI
Exposures Product Safety
News headline image
Why Is MoonLake Immunotherapeutics Stock Soaring Monday? ↗
Via Benzinga
Exposures Product Safety
News headline image
A Blood Test That Screens for 50+ Cancers Just Moved Closer to Real-World Use. Here's What It Means for Grail Investors. ↗
Via The Motley Fool
Tickers GRAL GS
Exposures Product Safety
News headline image
Lose the Fat. Keep the Muscle and the Face.
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Elon Musk's Mom Recalls Buying His Only $99 Suit As Billionaire-Turned-Trillionaire's Early Struggles Resurface: 'He Was Fine With That' ↗
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
News headline image
3 Biotech Firms With Major Potential Catalysts in the Coming Months ↗
Via MarketBeat
Topics Intellectual Property
Tickers ADMA KRYS VERA
Exposures Intellectual Property Product Safety
News headline image
Modern Overview of Psychedelic, Dissociative, and Cannabinoid Compounds ↗
Via Talk Markets
Exposures Product Safety
News headline image
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Tickers NTLA OMER
Exposures Product Safety
News headline image
Moderna Has Some Key Approvals Ahead. Is the Stock a Buy? ↗
Via The Motley Fool
Tickers MRNA
Exposures COVID-19 Product Safety
News headline image
Investors of Medline Inc. (NASDAQ: MDLN) are Encouraged to Contact Kaplan Fox Regarding the Investigation of Potential Securities Law Violations
Via TheNewswire.com
Tickers MDLN
Exposures Product Safety
News headline image
Investors of Medline Inc. (NASDAQ: MDLN) are Encouraged to Contact Kaplan Fox Regarding the Investigation of Potential Securities Law Violations
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
News headline image
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Via TheNewswire.com
Tickers FULC
Exposures Product Safety
News headline image
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Tickers FULC
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.